Long term atypical antipsychotic treatment improves cognitive performance in schizophrenia but not surpassing conventional antipsychotic drugs effects.

被引：0
|
作者：
Selva Vera, Gabriel [1 ]
Borras Barrachina, Aroa [2 ]
机构：
[1] Univ Valencia, Teaching Unit Psichiatry & Psychol Med, E-46003 Valencia, Spain
[2] Univ Jaime I, Castellon de La Plana, Spain
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2016年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
PM441
引用
收藏
页码：209 / 210
页数：2
相关论文
共 50 条
  • [1] The effects of atypical antipsychotic drugs on cognitive functioning in schizophrenia
    McGurk, SR
    Meltzer, HY
    [J]. SCHIZOPHRENIA RESEARCH, 1998, 29 (1-2) : 160 - 160
  • [2] Cognitive dysfunction in schizophrenia: Comparison of treatment with atypical antipsychotic agents and conventional neuroleptic drugs
    Gallhofer, B
    Bauer, U
    Lis, S
    Krieger, S
    Gruppe, H
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 1996, 6 : 13 - 20
  • [3] Atypical antipsychotic drugs in the treatment of schizophrenia
    Meltzer, HY
    [J]. NORDIC JOURNAL OF PSYCHIATRY, 2001, 55 (02) : 86 - 86
  • [4] Atypical antipsychotic drugs and long-term outcome in schizophrenia
    Weiden, P
    Aquila, R
    Standard, J
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 1996, 57 : 53 - 60
  • [5] Atypical antipsychotic drugs in the treatment of schizophrenia
    Degner, D
    Rüther, E
    [J]. NERVENHEILKUNDE, 1998, 17 (10) : 472 - 479
  • [6] Long-term efficacy and safety of atypical and conventional antipsychotic drugs in first episode schizophrenia
    McEvoy, JP
    Lieberman, JA
    Perkins, DO
    Hamer, RM
    Sharma, T
    Zipursky, RB
    Kahn, R
    Gur, RE
    Centorrino, F
    Glick, ID
    Green, AI
    Nemeroff, CB
    Rothschild, AJ
    Strakowksi, SM
    Tohen, M
    Tollefson, GD
    [J]. BIOLOGICAL PSYCHIATRY, 2003, 53 (08) : 65S - 65S
  • [7] Long-term efficacy and safety of atypical and conventional antipsychotic drugs in first episode schizophrenia
    McEvoy, J
    Lieberman, JA
    Perkins, D
    Hamer, RM
    Sharma, T
    Zipursky, R
    Kahn, R
    Gur, R
    Centorrino, F
    Glick, I
    Green, AI
    Nemeroff, C
    Rothschild, A
    Strakowski, S
    Tohen, M
    Tollefson, GD
    [J]. SCHIZOPHRENIA RESEARCH, 2003, 60 (01) : 313 - 313
  • [8] Long-term efficacy and safety of atypical and conventional antipsychotic drugs in first episode schizophrenia
    Sharma, T
    Lieberman, JA
    McEvoy, JP
    Perkins, DO
    Hamer, RM
    Zipursky, RB
    Kahn, RS
    Gur, RE
    Centorrino, F
    Glick, I
    Green, AI
    Nemeroff, CB
    Rothschild, AJ
    Strakowski, SM
    Tohen, M
    Tollefson, GD
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 : S134 - S135
  • [9] Effect of atypical antipsychotic drugs on cognitive function in schizophrenia
    Meltzer, HY
    McGurk, SR
    [J]. TREATMENT OF SCHIZOPHRENIA - STATUS AND EMERGING TRENDS, 2001, : 49 - 59
  • [10] Serum lipid profiles and schizophrenia: Effects of conventional or atypical antipsychotic drugs in Taiwan
    Huang, TL
    Chen, JF
    [J]. SCHIZOPHRENIA RESEARCH, 2005, 80 (01) : 55 - 59
12345